These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37898347)

  • 41. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonographically measured suprailiac adipose tissue is a useful predictor of non-alcoholic fatty liver disease in obese children and adolescents.
    Schlieske C; Denzer C; Wabitsch M; Oeztuerk S; Mason RA; Thiere D; Kratzer W
    Pediatr Obes; 2015 Aug; 10(4):260-6. PubMed ID: 25251446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
    Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
    Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease.
    Zou Y; Hu C; Kuang M; Chai Y
    BMC Gastroenterol; 2022 Mar; 22(1):134. PubMed ID: 35331166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
    Simon TG; Corey KE; Chung RT; Giugliano R
    Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization.
    Cheng J; Liu C; Hu K; Greenberg A; Wu D; Ausman LM; McBurney MW; Wang XD
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2783-2790. PubMed ID: 28789977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.
    Netaji A; Jain V; Gupta AK; Kumar U; Jana M
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):473-479. PubMed ID: 32146441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women.
    Corbould A; Bhathal PS; Dixon JB; O'Brien PE
    Metab Syndr Relat Disord; 2014 Aug; 12(6):311-9. PubMed ID: 24819229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
    Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
    Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.
    Musso G; Bo S; Cassader M; De Michieli F; Gambino R
    Am J Clin Nutr; 2013 Oct; 98(4):895-906. PubMed ID: 23985808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis.
    Yang B; Lu L; Zhou D; Fan W; Barbier-Torres L; Steggerda J; Yang H; Yang X
    Front Endocrinol (Lausanne); 2022; 13():1007944. PubMed ID: 36267567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Abdominal adipose area, serum adiponectin and leptin levels of nonalcoholic fatty liver disease in elderly males.].
    Tao T; Wu L; Shen BB; Zhao YJ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Feb; 17(2):120-3. PubMed ID: 19254460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis.
    Liu B; Li Y; Li Y; Liu Y; Yan Y; Luo A; Ren H; She Q
    Hepatol Int; 2019 Nov; 13(6):757-765. PubMed ID: 31432447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study.
    Miao Y; Tao H
    BMJ Open; 2023 May; 13(5):e069440. PubMed ID: 37147088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.